NPI: 1033357348 · WASHINGTON, DC 20020 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 01/23/2009
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 01/23/2009 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 25,967 | $389K |
| 2019 | 26,969 | $361K |
| 2020 | 18,173 | $357K |
| 2021 | 14,808 | $218K |
| 2022 | 13,332 | $252K |
| 2023 | 4,707 | $209K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 29,710 | 2,436 | $1.53M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 34,940 | 1,897 | $212K |
| J1756 | Injection, iron sucrose, 1 mg | 6,084 | 1,173 | $21K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 540 | 225 | $21K |
| J1270 | Injection, doxercalciferol, 1 mcg | 16,538 | 1,427 | $4K |
| 83970 | 1,640 | 1,127 | $234.94 | |
| 90674 | 34 | 32 | $153.92 | |
| A4657 | Syringe, with or without needle, each | 2,374 | 1,601 | $153.34 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 843 | 364 | $145.98 |
| 82728 | 2,365 | 1,431 | $113.29 | |
| 83550 | 1,997 | 1,232 | $66.46 | |
| 83540 | 2,371 | 1,427 | $52.35 | |
| 85041 | 2,131 | 1,335 | $25.98 | |
| 85048 | 2,084 | 1,306 | $21.88 | |
| G0008 | Administration of influenza virus vaccine | 64 | 56 | $4.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 116 | 25 | $1.88 |
| 87340 | 19 | 13 | $0.00 | |
| 90662 | 46 | 38 | $0.00 | |
| 82108 | 42 | 35 | $0.00 | |
| 84466 | 18 | 13 | $0.00 |